Neurological soft signs significantly differentiate schizophrenia patients from healthy controls
- PMID: 29183417
- DOI: 10.1017/neu.2017.29
Neurological soft signs significantly differentiate schizophrenia patients from healthy controls
Erratum in
-
Corrigendum to "Neurological soft signs significantly differentiate schizophrenia patients from healthy controls"; [Acta Neuropsychiatrica 2018;30(2):97-105].Acta Neuropsychiatr. 2019 Feb;31(1):61. doi: 10.1017/neu.2018.37. Epub 2019 Jan 9. Acta Neuropsychiatr. 2019. PMID: 30621804 No abstract available.
Abstract
Objective: Neurological soft signs (NSS) are a group of minor non-localisable neurological abnormalities found more often in patients with schizophrenia. The aim of the current study was to test for the effect of gender, age, parental age, age at onset and clinical symptomatology on NSS.Material and methodsThe study sample included 133 patients suffering from schizophrenia according to DSM-IV-TR (77 males and 56 females; aged 33.55±11.22 years old) and 122 normal controls (66 males and 56 females; aged 32.89±9.91 years old). The assessment included the Neurological Evaluation Scale (NES), and a number of scales assessing the clinical symptoms and adverse effects especially extrapyramidal. The statistical analysis included exploratory t-test, simple linear regression analysis, analysis of covariance and the calculation of correlation coefficients.
Results: The results of the current study confirm that NSS are more frequent in patients with schizophrenia in comparison with normal controls (Wilks=0.622, p<0.0001), but do not support an effect of gender, age, age at onset, paternal or maternal age, education, medication status or clinical subtype of schizophrenia on NES scores.DiscussionOverall these results suggest that NSS constitute an independent (from the rest of symptoms), core (present in the vast majority of patients) and trait (unrelated to age and probably to the stage of schizophrenia) symptom of schizophrenia which could be of value in the clinical assessment and research of schizophrenia. Overall these results are not in full accord with the literature, but they could serve to fill in gaps and inconsistencies observed so far.
Keywords: motor coordination; neurological abnormalities; schizophrenia; soft neurological signs.
Similar articles
-
12-Month stability of neurological soft signs in stabilized patients with schizophrenia.Nord J Psychiatry. 2019 Oct;73(7):451-461. doi: 10.1080/08039488.2019.1649724. Epub 2019 Aug 8. Nord J Psychiatry. 2019. PMID: 31393751
-
[Neurological soft signs in early onset schizophrenia].Encephale. 2015 Jun;41(3):209-14. doi: 10.1016/j.encep.2014.01.005. Epub 2014 May 20. Encephale. 2015. PMID: 24854724 French.
-
Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2022 Sep;272(6):1087-1096. doi: 10.1007/s00406-021-01357-6. Epub 2021 Nov 29. Eur Arch Psychiatry Clin Neurosci. 2022. PMID: 34842982
-
[Neurological soft signs: meaning and relevance along the course of psychiatric illness. An objective and rapid screening for psychosis?].Riv Psichiatr. 2012 Nov-Dec;47(6):465-78. doi: 10.1708/1178.13053. Riv Psichiatr. 2012. PMID: 23160107 Review. Italian.
-
[Neurological soft signs as a candidate for endophenotype of schizophrenia].Psychiatr Pol. 2014 Jan-Feb;48(1):5-18. Psychiatr Pol. 2014. PMID: 24946431 Review. Polish.
Cited by
-
The neural substrates of neurological soft signs in schizophrenia: a systematic review.Schizophrenia (Heidelb). 2022 Apr 26;8(1):42. doi: 10.1038/s41537-022-00245-9. Schizophrenia (Heidelb). 2022. PMID: 35853869 Free PMC article. Review.
-
One-year Outcome of First vs. Later Episode Schizophrenia: A Real-world Naturalistic Study.Clin Psychopharmacol Neurosci. 2020 Aug 31;18(3):434-444. doi: 10.9758/cpn.2020.18.3.434. Clin Psychopharmacol Neurosci. 2020. PMID: 32702222 Free PMC article.
-
Longitudinal trajectory of early functional recovery in patients with first episode psychosis.Schizophr Res. 2019 Jul;209:234-244. doi: 10.1016/j.schres.2019.02.003. Epub 2019 Feb 28. Schizophr Res. 2019. PMID: 30826261 Free PMC article.
-
The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia.Biomedicines. 2022 Nov 15;10(11):2939. doi: 10.3390/biomedicines10112939. Biomedicines. 2022. PMID: 36428507 Free PMC article.
-
Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study.Int J Neuropsychopharmacol. 2019 Nov 1;22(11):681-697. doi: 10.1093/ijnp/pyz053. Int J Neuropsychopharmacol. 2019. PMID: 31563956 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical